DMXB-Anabaseine

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameDMXB-Anabaseine
Drug Alias NameDMXB-A-SRDMXBADMXB-AGTS-21
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuronal acetylcholine receptor protein alpha-7 subunit agonists
TargetsNeuronal acetylcholine receptor protein alpha-7 subunit
Therapy Area/IndicationsSchizophreniaPsychotic DisordersAutistic Disorder +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesComentis Inc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Colorado Denver
Inactive CompaniesUniversity Of FloridaComentis Inc
Active IndicationsObesity
Inactive IndicationsSchizophreniaPsychotic DisordersAutistic Disorder +[6] 

Other Information

ATC CodeN/A
Related LinksN/A